Companies like Hims realized they could sell copycat versions of Novo Nordisk’s GLP-1 medicine Wegovy made legally by ...
No­vo Nordisk said Thurs­day that it plans to even­tu­al­ly halt all of its hu­man in­sulin pen pro­duc­tion glob­al­ly, ...